APA (7th ed.) Citation

M, M., A, S., DH, L., F, A., S, G., J, K., . . . N, E. (2026). Cardiovascular adverse events associated with bispecific antibodies in relapsed or refractory B-cell non-Hodgkin lymphomas. Journal of hematology & oncology, 19(1), . https://doi.org/10.1186/s13045-026-01809-3

Chicago Style (17th ed.) Citation

M, Munir, Sayed A, Lee DH, Awan F, Ghazi S, Kim J, Addison D, and Epperla N. "Cardiovascular Adverse Events Associated with Bispecific Antibodies in Relapsed or Refractory B-cell Non-Hodgkin Lymphomas." Journal of Hematology & Oncology 19, no. 1 (2026). https://doi.org/10.1186/s13045-026-01809-3.

MLA (9th ed.) Citation

M, Munir, et al. "Cardiovascular Adverse Events Associated with Bispecific Antibodies in Relapsed or Refractory B-cell Non-Hodgkin Lymphomas." Journal of Hematology & Oncology, vol. 19, no. 1, 2026, https://doi.org/10.1186/s13045-026-01809-3.